Human Growth Hormone (HGH) medications increase risks of colon, prostate & breas

[Guest guest]

Human Growth Hormone (HGH) medications increase risks of colon,

prostate and breast cancers.

 

Genetically Engineered Anti-Aging Medication (HGH) Poses Undisclosed

Cancer Risks, Warns Samuel S. Epstein, M.D.

http://www.preventcancer.com/avoidable/breast_cancer/hgh_risks.htm

 

Use of the genetically engineered human growth hormone (HGH) for

anti-aging medication has become a major growth industry. Suppliers

of HGH, including those offering mail order prescriptions, are

proliferating on websites and the Internet.

 

The Chicago-based seven-year-old American Academy of Anti-Aging

Medicine, with over 8000 members, promotes injectable HGH in

programs claiming to stop or even reverse aging, including

decreasing body fat, and increasing muscle mass and bone density.

However, practitioners of this burgeoning " health " industry are

either ignorant of or suppress well-documented information on the

grave cancer risks of HGH medication.

 

HGH induces growth promoting and other effects by stimulating the

liver to increase production of the natural Insulin-like Growth

Factor-1 (IGF-1) whose blood levels normally decline with advancing

age. However, there are numerous publications in prestigious peer

reviewed scientific journals showing that elevated IGF-1 levels are

strongly associated with major excess risks of colon, prostate, and

breast cancers; even minor elevations are associated with up to 7-

fold increased risks of breast cancer, risks almost as high as those

in women carrying genes (BRCA1 and BRCA2) with the strongest

hereditary predisposition. Additionally, IGF-1 inhibits the

programmed self-destruction (apoptosis) of cancer cells, thus

stimulating the growth and invasiveness of small, undiagnosed

cancers, besides increasing the resistance of cancers to

chemotherapy. For these reasons, anti-aging HGH medication,

compounded by failure to explicitly disclose its grave risks,

constitutes medical malpractice.

 

Learn more about IGF-1

 

There are also growing concerns on possible risks from the use of

HGH nutritional supplements, including oral sprays. It should,

however, be recognized that HGH absorption from the mouth and gut is

unlikely to be significant, in striking contrast to complete

absorption from injectable medication. Nevertheless, nutritional HGH

supplements should be phased out until it can be shown that they do

not elevate blood IGF-1 levels.

 

HGH medication should only be used by qualified endocrinologists for

highly restricted medical disorders, such as dwarfism due to

pituitary gland deficiency, as approved by the FDA in 1985; anti-

aging medication has never received such approval.

 

Source: Cancer Prevention Coalition Press Release – March 14, 2000

 

CONTACT:

Samuel S. Epstein, M.D.

 

Chairman, Cancer Prevention Coalition

 

c/o University of Illinois at Chicago

 

School of Public Health, M/C 922

 

2121 W. Taylor Street

Chicago, IL 60612

 

312-996-2297

 

epstein